FIELD: biotechnology.
SUBSTANCE: invention relates to recombinant plasmid DNA. The recombinant plasmid pAL2-T-WBMAG DNA is developed, including fragments of WT1, BAALC, MN1, ABL1 and GUSB genes. The invention is used as calibrators in RT-PCR and real-time detection of genespecific products in order to compare the expression of these genes in patients with acute myeloid leukemia (AML). WT1, BAALC and MN1 genes act as tumour progression markers, and ABL1 and GUSB genes - as expression normalizers.
EFFECT: invention allows to increase the assessment accuracy of the relative expression of these genes due to the DNA calibrators design that combine sequences of all markers, complex analysis of the WT1, BAALC and MN1 genes allows to evaluate therapy effectiveness in most cases of acute myeloid leukemia, including in patients without detected chromosomal aberrations.
4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT PLASMID DNA PAL2-T-EXP, USED TO CREATE DNA CALIBRATORS IN EVALUATING THE EFFECTIVENESS OF THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA | 2017 |
|
RU2670543C1 |
| METHOD FOR DIAGNOSING ACUTE LEUKEMIA AND KITS FOR ITS IMPLEMENTATION | 2021 |
|
RU2806591C2 |
| METHOD OF DIAGNOSING CLEAR CELL RENAL CELL CARCINOMA AND SET FOR ITS REALISATION | 2012 |
|
RU2545998C2 |
| DIAGNOSTIC TECHNIQUE FOR PAPILLARY CELL RENAL CARCINOMA AND SET FOR IMPLEMENTATION THEREOF | 2014 |
|
RU2605829C2 |
| METHOD OF DIAGNOSING CLEAR CELL RENAL CELL CARCINOMA AND SET FOR ITS REALISATION | 2012 |
|
RU2545995C2 |
| SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS AND FLUORESCENTLY LABELED DNA PROBES FOR DETERMINING THE EXPRESSION OF THE SOCS2, CD34, FAM30A, GPR56, DNMT3B, SPINK2 GENES, FOLLOWED BY DETERMINING THE LEVEL OF RELATIVE EXPRESSION RELATIVE TO THE ABL1 REFERENCE GENE, AMPLIFIED IN REAL-TIME PCR, USED TO PREDICT THE RISK OF EARLY RELAPSE IN CHILDREN WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION | 2022 |
|
RU2783950C1 |
| DIAGNOSTIC METHOD OF RENAL CELL CARCINONMA | 2016 |
|
RU2643586C1 |
| DIAGNOSTIC TECHNIQUE FOR CLEAR CELL RENAL ADENOCARCINOMA AND SET FOR IMPLEMENTATION THEREOF | 2009 |
|
RU2393472C1 |
| SET OF REAGENTS FOR THE DETERMINATION OF RIBONUCLEIC ACIDS IN THE DIAGNOSIS OF LYMPHOPROLIFERATIVE DISEASES | 2023 |
|
RU2802064C1 |
| SET OF SYNTHETIC OLIGODEOXYRIBONUCLEOTIDES AND A METHOD FOR QUANTIFYING THE VIRAL LOAD OF SARS-CoV-2 IN TISSUES OF VARIOUS ORGANS BY QUANTITATIVE POLYMERASE CHAIN REACTION IN REAL TIME | 2021 |
|
RU2761358C1 |
